All Rights Reserved. Forward ® 2024
2659 State Street, Suite 100 #17, Carlsbad. CA 92008

Terms & Conditions |

Privacy Policy

REGISTER NOW – Please select the webcast(s) you wish to attend and enter your contact details

Unlocking Capital for Global Biotech Innovation: Trends and Strategies

Partnering for success: Aligning scientific, commercial and financial goals

Break out of the bubble: Invest in Saudi’s untouched market

Country *

First Name *

Surname *

Phone Number

Company Name

Email *

Please tick these boxes if you do not wish to receive marketing information relevant to you from EBD Group

via Email

via Telephone

via Post

Please tick this box if you do not wish to be included on our third party mailing list to receive any related marketing communications from our third party partners

From the teams behind BIO-Europe, the LSX USA and Europe Congress's, and Asia Bio Partnering Forum, this high-level digital series delivers sharp, digestible insights into the shifting biopharma partnering and investment landscape. Created to keep the momentum going between major partnering events, it offers timely takes from industry leaders to keep you ahead of the curve. 

Whether you're gearing up for a pivotal meeting or scanning the horizon for what’s next, this series keeps you connected, informed, and one step ahead. To learn about sponsorship of future events, contact BioXconomy@informaconnectls.com 

October 13—15, 2026 | Virtual

Day 1 | Tuesday, October 13 | 09:00–09:50
Unlocking capital for global biotech innovation: Trends and strategies

• Emerging trends in venture capital and private

equity for biotech.

• Strategies for mitigating risks in biotech

investments.

• Insights into successful funding models and

portfolio diversification

Day 2 | Wednesday, October 14 | 09:00–09:50
Partnering for success: Aligning scientific, commercial and financial goals

• Strategies for aligning scientific innovation

with commercial and financial objectives

• Building partnerships that balance risk,

reward, and long-term value creation

• Collaborative approaches to ensure mutual

success across all stakeholders

Day 3 | Thursday, October 15 | 09:00–09:50
Beyond the bench and building biotech powerhouses

• Capital and scale: How do biotech leaders

balance aggressive growth ambitions with

capital efficiency while navigating the

challenging path from Series A to IPO and

beyond?

• Governance as competitive advantage: What

governance structures and board compositions

enable biotech companies to make faster, smarter

decisions while maintaining regulatory

compliance and stakeholder confidence?

• Value creation beyond valuation: How are

leading biotech executives redefining success

metrics to encompass patient outcomes,

partnership ecosystems, and long-term strategic

positioning rather than focusing solely on exit

multiples?